Medanta to Collaborate with John Hopkins University for Better Patient Outcomes
Medanta - The Medicity (www.medanta.org), in a multiple collaborator effort with global leaders - GHPL, Hopkins, MIER and Bionworks has received 1,20,000 USD (90 lakhs) competitive international grant from Pfizer Independent Grants for Learning &
Medanta – The Medicity (www.medanta.org), in a multiple collaborator effort with global leaders – GHPL, Hopkins, MIER and Bionworks has received 1,20,000 USD (90 lakhs) competitive international grant from Pfizer Independent Grants for Learning & Change (IGLC) (https://on.pfizer.com/2QxRADn) and The Joint Commission (JCI) (www.jointcommission.org) as part of Antimicrobial Stewardship program for the Asia-Pacific Region.
Medanta, along with the global leaders will be in competition with 13 international JCI accredited hospitals for an innovation to improve hospital care practices for appropriate antibiotic usage to improve patient outcomes, a practice that is a topical issue globally.
- The Joint Commission led the application evaluation process and provided oversight for the proposal review committee that made funding decisions
- The Joint Commission will be solely responsible for administering and overseeing project activities
- Pfizer IGLC will be solely responsible for all activities related to the provision of project funding
- All grant funding will be provided by Pfizer
On competing with 13 international JCI accredited hospitals, Dr. Naresh Trehan, Chairman and Managing Director, Medanta said, “In continuation to our commitment to world class treatment for all our patients, we are delighted to be a part of the Antimicrobial Stewardship Program to excel towards improved patient outcomes”.
Dr. Yatin Mehta, Chairman, Institute of Critical Care and Anaesthesiology, Medanta said, “There is a growing need to find a solution to antimicrobial resistance in a quick turn-around as it is one of the biggest challenges facing today’s healthcare providers. We are proud to be a part of this international program and hope to invent best solutions to curb the rise of anti- microbial resistance worldwide.”